Noor NM, Davies N, Tahir W, Bond S, et al. Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial. J Crohns Colitis 2025;19:jjaf150.
PMID: 41125135